healthy subject
Conditions
Interventions
Test product 1 applies to the designated area for 6 weeks
Test product 2 applies to the designated area for 6 weeks
Test product 3 applies to the designated area for 6 weeks
Control product applies
Sponsors
M&I Science CORP.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Japanese women between the ages of 20 and 65 at the time of obtaining written consent. 2.Subject who is aware of their skin dryness. 3.Subject who is able to strictly follow the instructions for use of the study products during the study period. 4.Subject who has been fully informed of the purpose and content of the study, is capable of consenting, understands the study well, voluntarily volunteers to participate in the study, and agrees to participate in the study in writing.
Exclusion criteria
Exclusion criteria: 1.Subject who has skin diseases (atopic dermatitis, contact dermatitis, etc.), traumatic injuries, or subjective symptoms such as pain that may affect the examination. 2.Subject who is attending a dermatological clinic at the time of consent. 3.Subject who has a serious disease or disorder that would make participation in the study a risk to the subject. 4.Subject with a history of hypersensitivity to cosmetics. 5.Subject is using or will use during the study period any drugs, health foods or supplements that are known to affect the study. 6.Subject is receiving hormone replacement therapy. 7.Subject who has a history of cosmetic therapy that may affect the study site. 8.Subject who has used cosmetic devices or cosmetic appliances within 1 month of obtaining consent. 9.Subject who has participated in another clinical trial (research) within 1 month of obtaining consent or who plans to participate in another clinical trial (research) during the study period. 10.Subject who is currently pregnant or lactating, or who may become pregnant or lactating during the study period. 11.Subject who is considered as an inappropriate candidate by the doctor in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stratum corneum water content | — |
Secondary
| Measure | Time frame |
|---|---|
| Transepidermal water loss, Texture, Skin viscoelasticity | — |
Countries
Japan
Contacts
Public ContactMasao Matsuoka
M&I Science CORP. Clinical Development Department
Outcome results
None listed